Our Pipeline
Our lead diagnostic and therapeutic programs are progressing through preclinical evaluation and first-in-human studies.
Stay up to date with the latest from NuclideTx
From research breakthroughs and company milestones to opportunities to develop your career as we shape the future of radionuclide therapy.






